Concepedia

Changlong Shi

CS

Statistics

Publications

4

Citations

87

H-Index

4

Active since

2020

Affiliations

China Medical University(Current)

Changlong Shi is an author at China Medical University specializing in oncology, molecular oncology, and medicine.

Publications per year

2020–2022

4

Publications

4

Overexpression of NuSAP1 is predictive of an unfavourable prognosis and promotes proliferation and invasion of triple-negative breast cancer cells via the Wnt/β-catenin/EMT signalling axis

Li Sun, Changlong Shi, Shaozhuang Liu et al. · Gene · 2020 · 44 citations

Medicine, Molecular Biology, Oncology +16

Sparstolonin B exerts beneficial effects on prostate cancer by acting on the reactive oxygen species‐mediated PI3K/AKT pathway

Shaozhuang Liu, Jiapeng Hu, Changlong Shi et al. · Journal of Cellular and Molecular Medicine · 2021 · 19 citations · Full text

Medicine, Oncology, Urology +17

Overexpression of Karyopherin Subunit alpha 2 (KPNA2) Predicts Unfavorable Prognosis and Promotes Bladder Cancer Tumorigenicity via the P53 Pathway

Changlong Shi, Li Sun, Shaozhuang Liu et al. · Medical Science Monitor · 2020 · 14 citations · Full text

Medicine, Molecular Biology, Oncology +17

Construction of an lncRNA model for prognostic prediction of bladder cancer

Changlong Shi, Yifei Li, Enming Wan et al. · BMC Medical Genomics · 2022 · 10 citations · Full text

Medicine, Bioinformatics, Oncology +17

1–4 of 4